We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

By LabMedica International staff writers
Posted on 17 Aug 2014
Print article
The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research.

Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better determine biologic systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years, according to a recent market report published by Grand View Research, Inc. (San Francisco, CA,USA), a market research and consulting company.

Computational genomics for cellular and biologic simulation applications lead the market in 2013, accounting for over 47% of global revenue. Major factors fueling demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and three-dimensional (3D) protein structure analysis.

Further key findings from the study suggest that North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is mostly credited to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and advances in biologic computation technology. It is expected that Asia Pacific will see the most rapid growth in the market, at an estimated CAGR of 28.0% due to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.

Another finding included that the application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22%, due to the swing in sequencing studies towards additional analysis of the nature of various biologic proteins as a part of development of personalized medicine.

Drug discovery and disease modelling applications were found to dominate the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk, and Eli Lilly.

Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biologic and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biologic data is expected to witness the fastest CAGR of over 21.0%. Major companies in this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus, and others.

Grand View Research provides customized research reports and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy.

Related Links:

Grand View Research


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.